How Can We Help You?

Quick Info:

Find a Doctor Specialties (800) 213-3284

Go To Home PageBack

Prostate Cancer Trials

Select Clinical Trial

Alliance A031201: Phase III Trial of Enzalutamide (NSC# 766085) Versus Enzalutamide, Abiraterone and Prednisone for Castration Resistant Metastatic Prostate Cancer

  • Men, ages 18 and older, diagnosed with progressive castration-resistant metastatic prostate cancer. For additional criteria, call our Clinical Trials office at (910) 715-2200.






Clara McLean House
Make a Donation
News & Events